645 related articles for article (PubMed ID: 17368974)
1. WHI risks: any relevance to menopause management?
Burger HG
Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
[TBL] [Abstract][Full Text] [Related]
2. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
3. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
4. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
6. Risks of hormone therapy in the 50-59 year age group.
van de Weijer PH
Maturitas; 2008 May; 60(1):59-64. PubMed ID: 18556157
[TBL] [Abstract][Full Text] [Related]
7. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
8. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
9. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone therapy in clinical perspective.
Hodis HN; Mack WJ
Menopause; 2007; 14(5):944-57. PubMed ID: 17353803
[TBL] [Abstract][Full Text] [Related]
11. A clinician's review of the WHI-related literature.
Speroff L
Int J Fertil Womens Med; 2004; 49(6):252-67. PubMed ID: 15751264
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
Mikkola TS; Clarkson TB; Notelovitz M
Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
[TBL] [Abstract][Full Text] [Related]
13. Are there second thoughts about the results of the WHI study?
Haimov-Kochman R; Hochner-Celnikier D
Acta Obstet Gynecol Scand; 2006; 85(4):387-93. PubMed ID: 16612699
[TBL] [Abstract][Full Text] [Related]
14. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
[TBL] [Abstract][Full Text] [Related]
15. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.
Genazzani AR; Schneider HP; Panay N; Nijland EA
Gynecol Endocrinol; 2006 Jul; 22(7):369-75. PubMed ID: 16864146
[TBL] [Abstract][Full Text] [Related]
16. When is it appropriate to prescribe postmenopausal hormone therapy?
Ettinger B; Barrett-Connor E; Hoq LA; Vader JP; Dubois RW
Menopause; 2006; 13(3):404-10. PubMed ID: 16735937
[TBL] [Abstract][Full Text] [Related]
17. Is there a place for postmenopausal hormone therapy use in women with lupus?
Gompel A; Piette JC
Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer.
La Vecchia C
Breast; 2004 Dec; 13(6):515-8. PubMed ID: 15563861
[TBL] [Abstract][Full Text] [Related]
19. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
Motolese M
Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
[TBL] [Abstract][Full Text] [Related]
20. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
